Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Stock Analysis

What Neurotech International's (ASX:NTI) Phase 3 Autism Trial Launch Means for Its Path to FDA Registration

The commencement of dosing advances NTI164 into pivotal Phase 3 clinical development, which is the final and most significant trial stage before regulatory submission. The study is a national, multi-centre, randomised, double-blind, placebo-controlled design — the gold standard for pharmaceutical clinical evidence — evaluating …

Sonal Goyal | 03 November 2026

How Nova Minerals (ASX:NVA) Cleared All Permits for Its Alaska Antimony Project With 2027 Production in Sight

The permits were secured in approximately three months from the date of submission — a notably rapid turnaround that the company attributed in part to the project's strategic significance within US critical minerals policy. The approvals authorise construction andOperating Activitiesover an initial three-year term.

Sonal Goyal | 03 November 2026

How Novo Resources (ASX:NVO) Is Betting on Tibooburra Gold with a New Joint Venture and 2,700m Drill Program

The timing is significant. Novo's 2025 drill campaign at the Clone prospect delivered results that caught attention, including a headline intercept of 12 metres at 5.90 grams per tonne gold from 16 metres, which included a higher-grade shoot of 5 metres at 13.74 g/t …

Sonal Goyal | 03 November 2026

How OD6 Metals (ASX:OD6) Used Geophysics to Uncover Deep Fluorspar Targets at the Quinn Canyon Project

The CSAMT technique works by measuring variations in electrical resistivity in rocks down to depths exceeding 500 metres. Fluorspar — or calcium fluoride (CaF2) — is electrically resistive, meaning it creates a measurable contrast against surrounding geology that CSAMT can map. The method has …

Sonal Goyal | 03 November 2026

Why Auris Minerals (ASX:AUR) is re-sampling Morck Well gold drilling in Western Australia

Auris Minerals Limited is a Perth-based explorer for gold and base metals, listed on the ASX since 15 March 2001. The ASX classifies it within the Materials sector. Its shares are ordinary shares, and the company reports no operating revenue.

Sonal Goyal | 03 November 2026

Why PYC Therapeutics (ASX:PYC) is running peptide-drug trials across kidney and eye disease

PYC Therapeutics Limited is a Perth-based biotechnology company, listed on the ASX since 30 March 2005 and classified by the ASX in Health Care. Its shares are ordinary shares, and the ASX lists it in the S&P/ASX 300, All Ordinaries and Small Ordinaries indices.

Sonal Goyal | 03 November 2026

Why Oceana Metals (ASX:OCN) has four rigs drilling Brazil's Serra Negra rare earths project

Oceana Metals Limited is a Perth-based mineral exploration company, listed on the ASX on 1 July 2022 and classified in the Materials sector. Its shares are ordinary shares. It earns no operating revenue, so its fortunes depend on exploration results and its ability to …

Sonal Goyal | 03 November 2026

Why Thrive Tribe Technologies (ASX:1TT) is shifting from wellbeing apps to veteran services

Thrive Tribe Technologies Limited has been listed on the ASX since 9 July 2015 and is classified in Information Technology, within Software and Services. The ASX describes it as providing a cloud-based software-as-a-service app that helps businesses communicate with employees through mobile, collaborative tools. …

Sonal Goyal | 03 November 2026

Why Great Dirt Resources (ASX:GR8) is chasing lithium targets under Pilbara sand cover

Great Dirt Resources Ltd is a mineral explorer admitted to the ASX in November 2023 and classified in the Materials sector. Its shares are ordinary shares, and it has no operating revenue.

Sonal Goyal | 03 November 2026

Why Pathkey.AI (ASX:PKY) is moving from marketing software into AI-assisted chip design

The ASX describes Pathkey.AI as the owner and operator of a user-generated content marketing platform. ItsQuarterly Reportalso describes TrialKey, a tool that assesses draft clinical-trial protocols, benchmarks competitors and compares indicative costs.

Sonal Goyal | 03 November 2026
Support

Hi! How can we help you today?

Loading…